USE OF LAQUINIMOD FOR TREATING CROHNS DISEASE PATIENTS WHO FAILED FIRST-LINE ANTI-TNFALPHA THERAPY
- 专利权人:
- 发明人:
- 申请号：
- HK17100625.4
- 公开号：
- HK1226961A
- 申请日:
- 2017.01.18
- 申请国别(地区):
- HK
- 年份:
- 2017
- 代理人:
- 摘要：
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Use of laquinimod for Treatment of patients with Crohn's disease who failed therapy to anti tumour necrosis factor (anti TNFa), First Line
- Use of laquinimod for treating Crohns disease patients who failed first-line anti-TNFa therapy
- SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
- SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
- SPLICE SWITCHING OLIGOMERS FOR TNF SUPERFAMILY RECEPTORS AND THEIR USE IN TREATMENT OF DISEASE
